Private Label Salicylic Acid Body Scrub Manufacturer Low MOQ

Most private label manufacturers that specialize in OTC-grade salicylic acid body scrubs will accept MOQs between 100 and 500 units for startup brands. The floor depends on three things: whether you use a stock formula or a custom one, the complexity of your packaging, and whether you require OTC drug labeling. Stock formula + stock packaging is the fastest path to a low MOQ. A manufacturer already running a salicylic acid scrub base can fill your order without investing in a new formula development cycle, so some will go as low as 100 units. Custom formulas require a development deposit and a minimum volume that justifies the R&D cost — typically 250–500 units at minimum for a first run, with the expectation of reorders. Packaging choice moves the MOQ significantly. Glass jars often require a 500-unit minimum from the jar supplier alone, before the manufacturer even starts filling. HDPE tubs and aluminum tins typically have lower packaging MOQs (250 units) and are easier to source domestically. If you want custom-molded packaging or embossed closures, expect MOQs of 1,000–3,000 on the packaging side, which will drive your finished-goods MOQ up regardless of what the manufacturer is willing to fill. OTC drug status adds complexity. If you plan to market acne treatment claims, you need a manufacturer registered with the FDA as an OTC drug establishment. Fewer manufacturers hold that registration, and their internal compliance overhead means they rarely go below 250 units per SKU. Some require a signed quality agreement before they'll discuss pricing. For brands that genuinely need fewer than 100 units — for test markets, influencer gifting, or DTC pilots — some formulators offer a "proto batch" or "pilot batch" service at a flat fee ($300–$800) that produces 20–50 units. This is not a commercial production run; it's meant for photography, sampling, and market validation before committing to a full MOQ. AJ Cosmo Labs lets you filter manufacturers by MOQ on the iOS app, so you only see suppliers that match your actual run size. That alone saves founders several weeks of back-and-forth with manufacturers whose minimums don't fit.

The all-in cost to launch a private label salicylic acid body scrub — from formulation through finished, labeled, shelf-ready units — typically falls in three bands depending on scale. For a 100–250 unit startup run, expect $6–$14 per unit in cost of goods sold (COGS). That figure includes the fill cost, raw materials (pharmaceutical-grade salicylic acid runs $20–$40/kg at small quantities), physical exfoliant, emulsifiers, preservatives, fragrance, and basic label printing. It does not include your development deposit ($300–$800 for a stock formula customization, $1,500–$4,000 for a fully custom formula), stability testing ($800–$2,500 depending on scope), or FDA OTC registration assistance if you need it. For 250–1,000 units, COGS typically drops to $4–$8 per unit as bulk raw material pricing kicks in and the manufacturer's filling labor is spread across more units. At this tier you can usually afford modest custom packaging (a labeled HDPE tub or a printed aluminum tin) without blowing the unit economics. For 1,000–5,000+ units, COGS can reach $2.50–$5 per unit, and your manufacturer can typically supply a full stability dossier, allergen declarations for EU compliance, and retailer-specific documentation (Target, Whole Foods, and Amazon all have different new-vendor packet requirements). Hidden costs that first-timers routinely underestimate: freight from manufacturer to your 3PL or warehouse (typically $0.30–$1.50/unit depending on distance and mode), sample/proto costs before production approval, artwork dielines and prepress fees ($150–$500 per SKU), and the cost of a cosmetic chemist or regulatory consultant review if you're making OTC acne claims ($150–$300/hour, usually 4–10 hours of work per SKU). The common mistake at the startup tier is optimizing only for COGS and ignoring development and compliance costs. A manufacturer quoting $3/unit with a $5,000 development fee and $2,500 stability study may be more expensive total than one quoting $7/unit with a $500 stock-formula fee and included stability data. When you post a brief on AJ Cosmo Labs, manufacturers submit structured quotes that break out fill cost, raw material cost, and ancillary fees separately, making true cost comparison straightforward.

From signed contract and deposit to finished goods in your hands, a private label salicylic acid body scrub typically takes 8–14 weeks. The range is wide because timeline is driven by which stage requires the most iteration. Weeks 1–2: Brief finalization and formula selection. If you're using a stock formula, this phase is short — you review the formula, approve the ingredient list, and sign off on the regulatory positioning. Custom formula development adds 2–4 weeks here as the cosmetic chemist runs initial bench batches. Weeks 2–5: Raw material and packaging procurement. Pharmaceutical-grade salicylic acid is available from a handful of qualified suppliers; standard lead time is 2–3 weeks. Physical exfoliants (sea salt, sugar, rice bran) are typically in stock. Custom-printed packaging — jars with labels, aluminum tins with debossed lids — can take 3–6 weeks and is often the critical path item that extends timelines. Weeks 4–8: Pilot batch and stability initiation. A pilot batch of 5–10 kg is produced, tested for pH, viscosity, microbial limits, and salicylic acid assay. Accelerated stability is initiated (40°C / 75% RH). Most manufacturers will release product to production while accelerated stability is in progress, accepting the risk that a stability failure triggers a reformulation — but they should disclose this practice. Weeks 8–12: Full production run, QC, and filling. Depending on the manufacturer's scheduling queue, production may start immediately after pilot approval or wait 2–4 weeks for a slot. Filling and labeling a 250-unit run is typically a single day of production but may be scheduled weeks out. Weeks 12–14: Finished goods QC, documentation, and shipment. Batch records, CoAs, and allergen declarations are compiled. Freight to your warehouse or 3PL adds 1–5 business days domestically. Timeline killers to watch: label artwork errors that require reprinting (allow 10 business days for artwork approval and print lead time), regulatory back-and-forth on OTC claims, and manufacturers with backlogged production queues. Always ask for a production schedule in writing at contract signing. AJ Cosmo Labs lets you track sample and production milestones directly in the iOS app so you always know where your batch stands without chasing emails.

In the United States, a salicylic acid body scrub does not require premarket FDA approval if it meets the requirements of the OTC Drug Monograph system — specifically the Over-the-Counter Drug Monograph for Acne (21 CFR 333). This monograph permits salicylic acid at 0.5–2% concentration as a recognized acne-treatment active, provided the product carries a compliant Drug Facts panel and is manufactured in an FDA-registered OTC drug establishment. What this means practically: your product is legal to sell without submitting a New Drug Application (NDA), but you must comply with a set of requirements that go significantly beyond standard cosmetic compliance. These include: listing your product with the FDA using a National Drug Code (NDC), manufacturing in a facility registered under 21 CFR Part 207, following cGMP standards under 21 CFR Part 211 (stricter than ISO 22716 cosmetic GMP), using only permitted inactive ingredients, and labeling with the exact Drug Facts format specified in the monograph. If you drop the acne treatment claim and market the product purely as an exfoliating body scrub with no drug claims — even if it contains salicylic acid at low concentrations — it may be classified as a cosmetic. However, FDA scrutiny applies if the ingredient's presence implies a drug benefit; "unclogs pores" and "treats blackheads" language typically triggers drug classification regardless of how the label is structured. In the European Union, salicylic acid in rinse-off body products is permitted up to 2% with specific labeling restrictions. Leave-on products have stricter concentration limits. Products sold in the EU are regulated under EU Cosmetics Regulation 1223/2009 and do not use the US OTC drug framework — a separate Cosmetic Product Safety Report (CPSR) is required. In Canada, salicylic acid acne products are regulated as Natural Health Products or Drug Products depending on claims, and require a product license from Health Canada before sale. The most common mistake first-time founders make is choosing a cosmetic-only manufacturer (not FDA OTC registered) and then later discovering their intended acne marketing claims require a drug-registered supply chain — forcing an expensive manufacturer switch mid-launch. Always confirm your manufacturer's FDA registration status before signing a development contract if you intend to make any acne, blemish, or pore-related claims.

For an OTC acne-treatment body scrub sold in the United States, the FDA monograph permits salicylic acid at 0.5–2% by weight. The most commercially common concentrations are 1% and 2%. A 2% concentration is typically used for body products targeting keratosis pilaris, bacne (back acne), and rough skin on arms and legs, where skin is thicker and more tolerant than facial skin. A 1% concentration is gentler and appropriate for brands positioning around sensitive-skin or daily-use messaging. Below 0.5%, salicylic acid can still provide exfoliating benefit as a cosmetic ingredient (not requiring a Drug Facts panel), but claims must be limited to exfoliation and texture improvement — no acne, blemish, or pore-related language. This is a path some indie brands take to simplify compliance, accepting a weaker efficacy story in exchange for lower regulatory overhead. Above 2%, salicylic acid in a leave-on or semi-rinse product is not covered by the OTC monograph and would require an NDA or an authorized healthcare-provider pathway — not viable for consumer retail. Rinse-off scrub products get slightly different treatment because contact time is shorter, but most manufacturers and regulatory consultants still advise staying within the 0.5–2% window to remain monograph-compliant. From a formulation standpoint, salicylic acid is lipophilic and dissolves better in oil or alcohol-based vehicles than in water. In a sugar or salt scrub base, it's often dissolved in a carrier oil (jojoba, caprylic/capric triglycerides) or a glycol (propylene glycol, butylene glycol) before being incorporated into the bulk. pH is the other critical variable: salicylic acid is most active and stable at pH 3–4. Formulators use lactic acid or citric acid to adjust pH downward; some scrub bases with high glycerin or humectant content naturally buffer at pH 5–6, which reduces efficacy. A cosmetic chemist reviewing your formula should provide a finished-product assay (HPLC method is standard) confirming the salicylic acid concentration is within label claim ± 10% — this is a GMP requirement for OTC drug products and a good practice for cosmetics. When you use AJ Cosmo Labs to post a brief for a salicylic acid scrub, include your target concentration and intended claims so manufacturers can immediately flag whether their facility and formula catalog are the right fit.

Finding a low-MOQ manufacturer for a salicylic acid body scrub is harder than finding one for a plain body scrub because the OTC drug supply chain is smaller than the cosmetic-only supply chain. Many directories and sourcing platforms list thousands of cosmetic contract manufacturers but fail to distinguish which ones hold FDA OTC drug establishment registration — and for a salicylic acid acne product, that distinction is disqualifying if your manufacturer doesn't have it. The most reliable approach combines three channels: industry directories with regulatory filters, trade shows, and B2B marketplaces that pre-screen for compliance credentials. Industry directories: The FDA's publicly searchable Drug Establishment Registration database (accessible at fda.gov) lets you look up whether a specific manufacturer holds an active OTC drug establishment registration. Cross-reference any manufacturer you find on general directories (ThomasNet, Maker's Row, Alibaba) against this database before reaching out. Domestic US manufacturers are generally easier to audit and have shorter freight lead times; offshore manufacturers (China, South Korea, India) often have lower COGS but require more diligence on GMP audit documentation and import compliance. Trade shows: In-Cosmetics North America, Cosmoprof North America, and the NYSCC Suppliers' Day all have exhibitors in the private label OTC space. Walking the floor and having a 10-minute conversation is far more efficient than cold emails — you can ask OTC registration questions face to face and get a real sense of a manufacturer's capabilities. B2B marketplaces: AJ Cosmo Labs is an iOS app and marketplace that pre-vets manufacturers across CPG industries, including cosmetics and OTC-adjacent personal care. You post a brief describing your salicylic acid body scrub — target concentration, MOQ, packaging preference, OTC vs. cosmetic positioning — and receive structured responses from manufacturers who have already indicated their MOQ floor and compliance credentials. The app's MOQ filter lets you surface only suppliers that work at your run size, and in-app messaging keeps all communication in one place with a timestamped record. Red flags when evaluating manufacturers: no FDA registration number they can provide on request, inability to share a redacted CoA from a comparable formula, unwillingness to do a small proto batch before full production, and vague answers about who owns the formula IP after development. Green flags: proactive mention of Drug Facts panel requirements, references from brands in a similar size tier, a clear proto-to-production timeline in writing, and a quality agreement template they've used before. Download AJ Cosmo Labs from the App Store and post your brief to start receiving responses from manufacturers who specialize in exactly this category.

Yes, but the regulatory framework is completely different from the US, and a product built to US OTC drug standards does not automatically comply with EU or UK rules — in some respects the requirements overlap, and in others they conflict. In the EU, all cosmetic products — including those containing salicylic acid — are regulated under EU Cosmetics Regulation 1223/2009. Salicylic acid is a regulated ingredient listed in Annex III of that regulation. For rinse-off hair and body products, it is permitted up to 2% (with the condition "not to be used in products for children under 3 years" and the label warning "contains salicylic acid"). For face products, the same 2% limit applies for rinse-off use. Leave-on products have stricter limits. Crucially, the EU does not have an OTC drug monograph system — acne treatment claims are regulated as either cosmetic claims ("cleansing," "exfoliating") or medicinal claims requiring a full marketing authorization. Marketing a product as an acne treatment in the EU triggers medicinal product classification, which is a completely different and far more burdensome regulatory pathway. Practical implication: most brands selling salicylic acid body scrubs in the EU position them as exfoliating products with skin-smoothing claims, avoiding the word "acne" on EU-facing labeling entirely, even if the US version carries Drug Facts. You also need a Responsible Person (RP) established in the EU or UK (post-Brexit, the UK has its own Cosmetics Regulation that mirrors the EU version but requires a separate UK RP). The RP holds the Product Information File (PIF), which must include a Cosmetic Product Safety Report (CPSR) signed by a qualified safety assessor, a full INCI formula, stability data, and challenge test results. Fragrance allergen disclosure is stricter in the EU than the US: 26 allergens must be listed by name on the label if present above threshold concentrations (0.01% leave-on, 0.1% rinse-off). Lead time to prepare EU/UK compliance documentation from scratch is typically 6–12 weeks depending on whether your manufacturer already has an ISO 22716 audit and whether your safety assessor has a backlog. Budget $1,500–$4,000 for CPSR preparation depending on formula complexity. If you are targeting both US and EU markets, work with a manufacturer and regulatory consultant who have dual-market experience from the start — retrofitting EU compliance onto a US OTC supply chain is possible but time-consuming. AJ Cosmo Labs connects founders with manufacturers and formulators who have multi-market experience, which you can specify in your project brief when you post on the app.